Line 30: | Line 30: | ||
<div class="body-container" style="padding-left:0"> | <div class="body-container" style="padding-left:0"> | ||
− | + | <div> | |
<center> | <center> | ||
<img src="https://static.igem.org/mediawiki/2017/9/97/T--CPU_CHINA--mainpage_new.png" width = "1300"> | <img src="https://static.igem.org/mediawiki/2017/9/97/T--CPU_CHINA--mainpage_new.png" width = "1300"> | ||
</center> | </center> | ||
+ | </div> | ||
+ | |||
+ | <div> | ||
<h5>Our HEAD-Treg</h5> | <h5>Our HEAD-Treg</h5> | ||
<center> | <center> | ||
<video src="https://static.igem.org/mediawiki/2017/1/14/T--CPU_CHINA--mainpagevideo.mp4" controls="controls" class="video" width = "60%"></video> | <video src="https://static.igem.org/mediawiki/2017/1/14/T--CPU_CHINA--mainpagevideo.mp4" controls="controls" class="video" width = "60%"></video> | ||
</center> | </center> | ||
+ | </div> | ||
+ | |||
+ | <div> | ||
<center><h3>Description</h3></center> | <center><h3>Description</h3></center> | ||
Line 47: | Line 53: | ||
inflammatory environment, which enables them to play their role of immunosuppression in lesions more | inflammatory environment, which enables them to play their role of immunosuppression in lesions more | ||
efficiently and more stably. <br>These two redirections of the two different but interrelated systems on Tregs ensure this novel therapy a promising anti-RA effect. </h4></center> | efficiently and more stably. <br>These two redirections of the two different but interrelated systems on Tregs ensure this novel therapy a promising anti-RA effect. </h4></center> | ||
+ | </div> | ||
− | + | </div> | |
</body> | </body> | ||
</html> | </html> |
Revision as of 12:07, 1 November 2017